We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

UPBD:NASDAQUpbound Group, Inc. Analysis

Data as of 2026-06-14 - not real-time

$18.94

Latest Price

8/10Risk

Risk Level: High

Executive Summary

Upbound Group (UPBD) trades at $18.94, well below its DCF‑derived fair value of $387, implying a potential upside of over 50% despite a 38% 30‑day volatility and a beta of 1.66, which signals heightened market sensitivity. The stock sits just above its 20‑day SMA (18.27) but below the 50‑day SMA (18.57) and the 200‑day SMA (19.92), confirming a bearish price trend, while the MACD histogram remains positive, hinting at a possible short‑term rebound. Fundamentally, the company delivers a solid dividend yield of 8.23% but a payout ratio of 108% raises questions about sustainability, especially given a debt‑to‑equity ratio above 240% and a max drawdown of 41%. Earnings estimates have been upgraded, reflected in a Zacks Rank 1 Strong Buy and a consensus mean target of $28.5, suggesting the market expects earnings acceleration. Revenue growth of 3.7% YoY and an improving EBITDA margin bolster confidence, yet the high leverage and modest operating margin (7.4%) temper enthusiasm. Recent news highlights the dividend declaration and analyst upgrades, providing short‑term catalyst support, while the technical resistance at $19.64 and support at $16.71 define the near‑term trading range. Overall, the stock appears deeply undervalued from a valuation perspective but carries notable financial and market risks.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 7/10

Key Factors

  • Technical bearish trend with price below key moving averages
  • Recent dividend declaration and ex‑date providing near‑term yield
  • Analyst upgrade to Zacks Strong Buy offering upside potential

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Significant valuation gap versus DCF fair value
  • Strong cash flow generation and positive free cash flow
  • Consensus analyst targets indicating earnings acceleration

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • High leverage and debt‑to‑equity ratio limiting financial flexibility
  • Dividend payout ratio above 100% creating sustainability concerns
  • Potential for business model stabilization and incremental revenue growth

Key Metrics & Analysis

Financial Health

Revenue Growth3.70%
Profit Margin1.78%
P/E Ratio13.2
ROE12.08%
ROA7.36%
Debt/Equity241.44
P/B Ratio1.5
Op. Cash Flow$328.2M
Free Cash Flow$1.6B
Industry P/E36.8

Technical Analysis

TrendBearish
RSI54.8
Support$16.71
Resistance$19.64
MA 20$18.27
MA 50$18.57
MA 200$19.92
MACDBullish
VolumeStable
Fear & Greed Index89.86

Valuation

Fair Value$387.52
Target Price$28.50
Upside/Downside50.48%
GradeUndervalued
TypeValue
Dividend Yield8.23%

Risk Assessment

Beta1.67
Volatility37.87%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.